NASDAQ:ARTV | News | Artiva Biotherapeutics, Inc.

ARTV News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-06Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-07-22Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 8.01.
2026-05-19Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.02.
2026-05-08Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,7.01,8.01,9.01.
2026-05-08Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2026-03-10Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-02-24Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.02.
2026-02-19Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.02.
2025-12-12Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.02.
2025-11-12Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-11-12Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01.
2025-08-06Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-06-25Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.02,5.07,9.01.
2025-05-08Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-03-24Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-01-29Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.02,9.01.
2024-11-12Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2024-10-22Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.02,9.01.
2024-08-29Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2024-07-22Current reportSEC filingArtiva Biotherapeutics, Inc. filed Form 8-KArtiva Biotherapeutics, Inc. filed Form 8-K covering items 5.03,9.01.